CNBX PHARMACEUTICALS INC. Other Comprehensive Income (Loss), Net of Tax
CNBX PHARMACEUTICALS INC. (CNBX) reported Other Comprehensive Income (Loss), Net of Tax of $2.57 million for the 12-month period ending 2023-08-31, per its 10-K filed 2024-11-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2024-11-29
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2022-08-31 was -$63.39K.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2022-05-31 was $42.26K.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2015-11-30 was -$570.50K, a 419.57% decline year-over-year.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2014-11-30 was $178.52K.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for fiscal 2023 was $2.57M.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$669.13K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2023-08-31 | $2.57M 10-K · filed 2024-11-29 | |||
| 2022-08-31 | -$63.39K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-30 | -$21.13K derived: sum of 2 quarters · filed 2023-11-30 | -$669.13K 10-K · filed 2023-11-30 | |
| 2022-05-31 | $42.26K 10-Q · filed 2023-07-14 | -$605.74K 10-Q · filed 2023-07-14 | ||
| 2015-11-30 | -$570.50K 10-Q · filed 2016-01-22 | |||
| 2014-11-30 | $178.52K 10-Q · filed 2016-01-22 |